Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dwivedi VK et al. – These enzyme activities along with MDA levels were improved and came back near to normal level after administration of cefepime plus amikacin (potentox) for 7 days in group III. These studies concluded that fixed–dose combination of potentox improved oxidant and antioxidant levels in pneumonia infection.

Related Articles

Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection
European Journal of Pediatrics, 11/17/09    Relevance Score: 82%

A novel inhibitor of Chlamydophila pneumoniae protein kinase D inhibits phosphorylation of CdsD and suppresses bacterial replication
BMC Microbiology, 10/21/09    Relevance Score: 82%

Monomicrobial necrotizing fasciitis in a white male caused by hypermucoviscous Klebsiella pneumoniae
Journal of Medical Microbiology, 10/21/09    Relevance Score: 82%

Bacterial Pneumonias during an Influenza Pandemic: How Will We Allocate Antibiotics
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 10/15/09    Relevance Score: 82%

Bacterial Coinfections in Lung Tissue Specimens From Fatal Cases of 2009 Pandemic Influenza A (H1N1)--United States, May-August 2009
JAMA, 11/04/09    Relevance Score: 81%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address